
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Insulin
Therapeutic Area : Endocrinology
Study Phase : Phase III
Sponsor : Oramed Pharmaceuticals
Deal Size : $47.0 million
Deal Type : Partnership
Lifeward Enters Strategic Partnership with Oramed for Biomedical Innovation
Details : As part of the partnership, Insulin will be developed to target the Insulin receptor for type 2 diabetes treatment.
Product Name : ORMD-0801
Product Type : Hormone
Upfront Cash : Undisclosed
January 13, 2026
Lead Product(s) : Insulin
Therapeutic Area : Endocrinology
Highest Development Status : Phase III
Sponsor : Oramed Pharmaceuticals
Deal Size : $47.0 million
Deal Type : Partnership
